48 related articles for article (PubMed ID: 38735933)
1. Integrated oral microgel system ameliorates renal fibrosis by hitchhiking co-delivery and targeted gut flora modulation.
Hou Y; Zhu L; Ye X; Ke Q; Zhang Q; Xie X; Piao JG; Wei Y
J Nanobiotechnology; 2024 Jun; 22(1):305. PubMed ID: 38822364
[TBL] [Abstract][Full Text] [Related]
2. Orally available dextran-aspirin nanomedicine modulates gut inflammation and microbiota homeostasis for primary colorectal cancer therapy.
Ma S; Yao H; Si X; Huang Z; Wang R; Wan R; Tang Z; Wang G; Song W
J Control Release; 2024 Jun; 370():528-542. PubMed ID: 38705520
[TBL] [Abstract][Full Text] [Related]
3. Management of Cardiovascular Diseases by Short-Chain Fatty Acid Postbiotics.
Mousavi Ghahfarrokhi SS; Mohamadzadeh M; Samadi N; Fazeli MR; Khaki S; Khameneh B; Khameneh Bagheri R
Curr Nutr Rep; 2024 Jun; 13(2):294-313. PubMed ID: 38656688
[TBL] [Abstract][Full Text] [Related]
4. Taking SCFAs produced by Lactobacillus reuteri orally reshapes gut microbiota and elicits antitumor responses.
Li N; Niu L; Liu Y; Wang Y; Su X; Xu C; Sun Z; Guo H; Gong J; Shen S
J Nanobiotechnology; 2024 May; 22(1):241. PubMed ID: 38735933
[TBL] [Abstract][Full Text] [Related]
5. Colon-Targeted Release of Turmeric Nonextractable Polyphenols and Their Anticolitis Potential via Gut Microbiota-Dependent Alleviation on Intestinal Barrier Dysfunction in Mice.
Yang W; Yang C; Du Y; Wang Q
J Agric Food Chem; 2023 Aug; 71(30):11627-11641. PubMed ID: 37470294
[TBL] [Abstract][Full Text] [Related]
6. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment.
Bender MJ; McPherson AC; Phelps CM; Pandey SP; Laughlin CR; Shapira JH; Medina Sanchez L; Rana M; Richie TG; Mims TS; Gocher-Demske AM; Cervantes-Barragan L; Mullett SJ; Gelhaus SL; Bruno TC; Cannon N; McCulloch JA; Vignali DAA; Hinterleitner R; Joglekar AV; Pierre JF; Lee STM; Davar D; Zarour HM; Meisel M
Cell; 2023 Apr; 186(9):1846-1862.e26. PubMed ID: 37028428
[TBL] [Abstract][Full Text] [Related]
7. Gut colonisation with multidrug-resistant Klebsiella pneumoniae worsens Pseudomonas aeruginosa lung infection.
Le Guern R; Grandjean T; Stabler S; Bauduin M; Gosset P; Kipnis É; Dessein R
Nat Commun; 2023 Jan; 14(1):78. PubMed ID: 36604442
[TBL] [Abstract][Full Text] [Related]
8. Precise oral delivery systems for probiotics: A review.
Luo Y; De Souza C; Ramachandran M; Wang S; Yi H; Ma Z; Zhang L; Lin K
J Control Release; 2022 Dec; 352():371-384. PubMed ID: 36309096
[TBL] [Abstract][Full Text] [Related]
9. Altered propionate metabolism contributes to tumour progression and aggressiveness.
Gomes AP; Ilter D; Low V; Drapela S; Schild T; Mullarky E; Han J; Elia I; Broekaert D; Rosenzweig A; Nagiec M; Nunes JB; Schaffer BE; Mutvei AP; Asara JM; Cantley LC; Fendt SM; Blenis J
Nat Metab; 2022 Apr; 4(4):435-443. PubMed ID: 35361954
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota-derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC.
Hu C; Xu B; Wang X; Wan WH; Lu J; Kong D; Jin Y; You W; Sun H; Mu X; Feng D; Chen Y
Hepatology; 2023 Jan; 77(1):48-64. PubMed ID: 35262957
[TBL] [Abstract][Full Text] [Related]
11. Targeting intestinal flora and its metabolism to explore the laxative effects of rhubarb.
Yang L; Wan Y; Li W; Liu C; Li HF; Dong Z; Zhu K; Jiang S; Shang E; Qian D; Duan J
Appl Microbiol Biotechnol; 2022 Feb; 106(4):1615-1631. PubMed ID: 35129656
[TBL] [Abstract][Full Text] [Related]
12. Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance.
Bell HN; Rebernick RJ; Goyert J; Singhal R; Kuljanin M; Kerk SA; Huang W; Das NK; Andren A; Solanki S; Miller SL; Todd PK; Fearon ER; Lyssiotis CA; Gygi SP; Mancias JD; Shah YM
Cancer Cell; 2022 Feb; 40(2):185-200.e6. PubMed ID: 34951957
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome and its role in colorectal cancer.
Rebersek M
BMC Cancer; 2021 Dec; 21(1):1325. PubMed ID: 34895176
[TBL] [Abstract][Full Text] [Related]
14. Microbial short-chain fatty acids modulate CD8
Luu M; Riester Z; Baldrich A; Reichardt N; Yuille S; Busetti A; Klein M; Wempe A; Leister H; Raifer H; Picard F; Muhammad K; Ohl K; Romero R; Fischer F; Bauer CA; Huber M; Gress TM; Lauth M; Danhof S; Bopp T; Nerreter T; Mulder IE; Steinhoff U; Hudecek M; Visekruna A
Nat Commun; 2021 Jul; 12(1):4077. PubMed ID: 34210970
[TBL] [Abstract][Full Text] [Related]
15. Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy.
Huang J; Liu D; Wang Y; Liu L; Li J; Yuan J; Jiang Z; Jiang Z; Hsiao WW; Liu H; Khan I; Xie Y; Wu J; Xie Y; Zhang Y; Fu Y; Liao J; Wang W; Lai H; Shi A; Cai J; Luo L; Li R; Yao X; Fan X; Wu Q; Liu Z; Yan P; Lu J; Yang M; Wang L; Cao Y; Wei H; Leung EL
Gut; 2022 Apr; 71(4):734-745. PubMed ID: 34006584
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives.
Dos Santos AM; Carvalho SG; Meneguin AB; Sábio RM; Gremião MPD; Chorilli M
J Control Release; 2021 Jun; 334():353-366. PubMed ID: 33901582
[TBL] [Abstract][Full Text] [Related]
17. Butyrate and the Fine-Tuning of Colonic Homeostasis: Implication for Inflammatory Bowel Diseases.
Gasaly N; Hermoso MA; Gotteland M
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802759
[TBL] [Abstract][Full Text] [Related]
18. Host-microbiota maladaptation in colorectal cancer.
Janney A; Powrie F; Mann EH
Nature; 2020 Sep; 585(7826):509-517. PubMed ID: 32968260
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
